Methicillin/oxacillin-resistant Staphylococcus aureus as a hospital and public health threat in Brazil

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 1, 2010, Pages 71-76

  Carvalho, Karinne Spirandelli ^a   Mamizuka, Elsa Masae ^b   Gontijo Filho, Paulo P ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Community acquired methicillin resistant Staphylococcus aureus; Methicillin resistant staphylococcus aureus; Nosocomial infections and community infections

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BRAZIL; CLEANING; COMMUNICABLE DISEASE; COMMUNITY HOSPITAL; DISEASE ACTIVITY; DISEASE CARRIER; ENDEMIC DISEASE; HAND WASHING; HEALTH HAZARD; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH PROBLEM; STAPHYLOCOCCUS AUREUS;

EID: 77954803031     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1413-8670(10)70014-3     Document Type: Article

References (65)

1. Millar BC, Loughrey A, Elborn JS, Moore JE. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007; 67:109-13.
2. Jevons MP. Celbenin - resistant Staphylococci. BMJ 1961; 1:124-5.
3. Parker MT, Hewitt JH. Methicillin resistance in Staphylococcus aureus. Lancet 1970; 1:800-4.
4. Boyce JM, White RL, Apruill EY. Impact of methicillin-resist-ant Staphylococcus aureus on the incidence of nosocomial sta-phylococcal infections. J Infect Dis 1983; 148(4):763.
5. Trindade PA, McCulloch JA, Oliveira GA, Mamizuka EM. Molecular Techniques for MRSA Typing: Current Issues and Perspectives. Braz J Infect Dis 2003; 7(1):32-43.
6. Sader H, Jones RN, Gales AC, Silva JB, Pignatari AC and the SENTRY participants. SENTRY Antimicrobial Surveillance Program Report: Latin America and Brazilian results for 1997 through 2001. Braz J Infect Dis 2004; 8(1):25-79.
7. Carvalho RH. Bactérias resistentes e multirresistentes a antibióticos nos pacientes internados em uma UTI de adultos de hospital universitário brasileiro. Uberlândia, 2007. 38p. Dissertação (Mestrado em Imunologia e Parasitologia Aplicadas) - Programa de Pós-Graduação em Imunologia e Parasitologia Aplicadas - Universidade Federal de Uberlândia, 2007.
8. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002; 99(11):7687-92.
9. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993; 25:97-108.
10. Herold BC, Immergluck LC, Maranan MC et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-98.
11. Vandenesch F, Naimi E, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwild emergence. Emerg Infect Dis 2003; 9:978-84.
12. Okuma K, Iwakawa K, Turnidge JD et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289-94.
13. Dufour P, Gillet Y, Bes M et al. Community-acquired methicil-lin resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819-24.
14. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases 2001; 7(2):178-82.
15. Etienne J. Panton-Valentine leukocidin: a marker of severity for Staphylococcus aureus infection? Clin Infect Dis 2005; 41:591-3.
16. US Centers for Disease Control and Prevention. Four pedi-atric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 19971999. MMWR Morb Mortal Wkly Rep 1999; 48:707-10.
17. Gillet Y, Issartel B, Vanhems P et al. Association between Sta-phylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-9.
18. US Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles Country, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:793-5.
19. Cunha BA. A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus CA-MRSA infections. J Hosp Infect 2008; 68(3):271-2.
20. Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982; 97:330-8.
21. Trindade PA, Pacheco RL, Costa SF, et al. Prevalence of SC-Cmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:3435-7.
22. Miranda OP, Silva-Carvalho MC, Ribeiro A et al. Emergence in Brazil of methicillin-resistant Staphylococcus aureus isolates carrying SCCmecIV that are related genetically to the USA800 clone. Clin Microbiol Infect 2007; 13:1165-72.
23. Ribeiro A, Coronado AZ, Silva-Carvalho MC et al. Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clones in Rio de Janeiro and Porto Alegre cities causing both community- and hospital-associated diseases. Diagn Microbiol Infect Dis 2007; 59:339-45.
24. Carvalho KS, da Trindade NV, Gontijo Filho PP. Aspectos microbiologicos e epidemiológicos de infecções por MRSA suspeitas de CA-MRSA adquiridas em um hospital univer-sitario brasileiro. In: Program and abstracts: III Congresso Mi-neiro de Infectologia Belo Horizonte, 2008.
25. Kluitmans J, Van Belkum A, Verbrugh H. Nasal carriage of Sta-phylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10:505-20.
26. Reinert C, McCulloch JA, Watanabe S, Ito T, Hiramatsu K, Mamizuka EM. Type IV SCCmec found in decade old Brazilian MRSA isolates. Braz J Infect Dis 2008; 12(3):213-6.
27. Lowy FD. Staphylococcus aureus infections. N. Engl. J. Med 1998; 339:520-32.
28. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003; 111:1265-73.
29. Fridkin SK, Hill HA, Volkova NV et al. Intensive Care Antimicrobial Resistance Epidemiology Project Hospitals. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002; 8:697-701.
30. Tiemersma EW, Bronzwaer SL, Lyytikainen O et al. European antimicrobial resistance surveillance system participants. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10:1627-34.
31. Diekema DJ, Pfaller MA, Schmitz FJ et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl. 2): S114-32.
32. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infection, Genetics and Evolution 2008; 8(6):747-763.
33. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Car-meli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-74.
34. Moreira MR, Cardoso RL, Almeida AB, Gontijo Filho PP. Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to Oxacillin in patients at Intensive Care Unit of a Brazilian University Hospital. Braz J Infect Dis 2008; 12(6):499-503.
35. Robinson DA, Enright MC. Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol 2004; 186:1060-4.
36. Hartman B, Tomasz A. Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 1981; 19:726-35.
37. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003; 6:41-52.
38. Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 2001; 7:349-61.
39. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48:2637-51.
40. Wielders CL, Vriens MR, Brisse S et al. In-vivo transfer of mecA DNA to Staphylococcus aureus. Lancet 2001; 357:1674-5.
41. Ito T, Katayama Y, Asada K et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylo-coccus aureus. Antimicrob Agents Chemother 2001; 45:1323-36.
42. Robinson DA, Enright MC. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 3926-34.
43. Enright MC. The evolution of a resistant pathogen - the case of MRSA. Curr Opin Pharmacol 2003; 3:474-9.
44. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDou-gal LK, Carey RB et al. Emergency Id Net Study Group (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
45. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U.S.A 2002; 99:7687-92.
46. Takano T, Higuchi W, Otsuka T et al. Novel characteristics of community-acquired methicillin-resistant Staphylococcus au-reus belonging to multilocus sequence type 59 in Taiwan. Antimicrob Agents Chemother 2008; 52:837-45.
47. Wannet WJ, Spalburg E, Heck ME et al. Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes in The Netherlands. J Clin Microbiol 2005; 43:3341-5.
48. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13:594-600.
49. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978-84.
50. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27:543-50.
51. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B. Prevalence and risk factors for carriage of methicillin-re-sistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003; 163:181-8.
52. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143:496-504.
53. Coia JE, Duckworth GJ, Edwards DI et al. Joint Working Party of the British Society of Antimicrobial Chemotherapy; Hospital Infection Society; Infection Control Nurses Association. Guidelines for the control and prevention of meticillin-resist-ant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63S:S1-44.
54. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Sta-phylococcus aureus infection in hospitals. J Hosp Infect 1998; 39:253-90.
55. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999; 159:821-6.
56. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997; 18:622-7.
57. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368:874-85.
58. Garner JS. Guideline for isolation precautions in hospitals. The hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 1996; 17:53-80.
59. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998; 41:11-8.
60. Santos KRN, Teixeira LM, Bravo Neto GP, Fonseca LS, Gontijo Filho PP. Mupirocin- and Methicillin-Resistant Staphylococcus aureus Spreading in an Intermediate-Care Unit in a Brazilian Hospital. Letter to the editor Infect Control and Hosp Epidemiol 1998; 19(9):622-3.
61. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA and Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html.
62. Ruhe JJ, Smith N, Bradsher RW and Menon A. Community onset methicillin- resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007; 44:777-84.
63. Miller LG, Quan C, Shay A et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44:483-92.
64. Robinson DA, Kearns AM, Holmes A. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 2005; 365:1256-8.
65. Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 2006; 367(9512):731-9.